The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
175 jobs Number of planned job creations
Announcement Date
25 March 2009
Employment effect (start)
1 April 2009
Foreseen end date
31 December 2012
Description
The American pharmaceutical group Baxter is about to create 175 new jobs between 2009 and 2012. The company already employs 2000 people and had already invested several millions and created hundreds of jobs in recent years in the Walloon region. The site of Lessines that produces immunodeficiency drugs will expand in order to increase its production in Europe. The Walloon government financially supports this expansion.
Sources
26 March 2009: Le Soir
26 March 2009: L'Echo
Citation
Eurofound (2009), Baxter, Business expansion in Belgium, factsheet number 68607, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/68607.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
